BMJ Analysis: Pharmaceutical research and development

Related PPRC Members: 
7 August 2012

Data indicate that the widely touted "innovation critis" in pharmaceuticals is a myth.  The real innovation crisis, say Donald Ligh and Joel Lexchin, stems from current current incentives that reward companies for developing large numbers of new drugs with few clinical advantages over existing ones.